Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Seattle Genetics CEO Siegall Sees Many Uses for Cancer Drug
Minyanville
Friday, June 15, 2012 - 11:05am
tags:
Seattle Genetics, Clay Siegall, Adcetris
SciClone Pharmaceuticals: Not Ready For Prime Time
Seeking Alpha
Friday, June 15, 2012 - 10:44am
tags:
SciClone
4 Companies With Upcoming Drug Approval Dates With 1 Potential Buyout Looming
Seeking Alpha
Friday, June 15, 2012 - 10:10am
tags:
Onyx, Carfilzomib, Arena Pharmaceuticals, lorcaserin, Vivus, Qnexa, AMR101, Amarin, Obagi Medical Products
Roche’s Zelboraf Fails To Win U.K. Drug-Cost Agency Backing
Bloomberg
Friday, June 15, 2012 - 10:08am
tags:
Roche, Zelboraf, UK, skin cancer
Pfizer Sees Harvard Collaboration As Spark For New Drugs
Bloomberg
Friday, June 15, 2012 - 10:05am
tags:
Harvard, Pfizer, cancer, R&D
Human Genome sets deadline for buyout offers
Yahoo/AP
Friday, June 15, 2012 - 10:04am
tags:
Human Genome Sciences, M&A, GSK
AbbVie Beyond Humira
Seeking Alpha
Friday, June 15, 2012 - 10:02am
tags:
Humira, AbbVie, Abbott Laboratories
FDA approves infant combo vaccine for meningitis - Menhibrix
Yahoo/AP
Friday, June 15, 2012 - 10:02am
tags:
MenHibrix, FDA, GSK
Patent Expirations Put Over $290 Billion in Rx Sales at Risk
Patent Baristas
Thursday, June 14, 2012 - 4:16pm
tags:
patents
Abbott: Buy Ahead Of The Split
Seeking Alpha
Thursday, June 14, 2012 - 4:10pm
tags:
Abbott Laboratories, AbbVie
Novartis to top pharma sales companies by 2018
Pharma Times, UK
Thursday, June 14, 2012 - 1:26pm
tags:
Novartis
PDL BioPharma expects 2 percent revenue growth on better sales of Herceptin, Lucentis, Tysabri
Yahoo/AP
Thursday, June 14, 2012 - 1:22pm
tags:
PDL Biopharma, guidance, Herceptin, Biogen Idec, Lucentis, Tysabri
Novelos Therapeutics Closes $5.4 Million Public Offering
Yahoo
Thursday, June 14, 2012 - 1:21pm
tags:
Novelos Therapeutics, stock offering
Dendreon shareholders gang up on CEO at annual meeting
Fierce Pharma
Thursday, June 14, 2012 - 1:18pm
tags:
Dendreon, Pharma CEOs, shareholders, John Johnson
Apricus Biosciences submits response for Vitaros market application
Yahoo/Fly on the Wall
Thursday, June 14, 2012 - 1:16pm
tags:
Apricus Biosciences, Vitaros, Switzerland, erectile dysfunction
PharmAthene Announces Further Progress In Development Of Its SparVax™ Anthrax Vaccine Program
Yahoo
Thursday, June 14, 2012 - 1:15pm
tags:
PharmAthene, SparVax, anthrax
Seattle Genetics updates survival data from Adcetris trial for Hodkin lymphoma
Yahoo/Fly on the Wall
Thursday, June 14, 2012 - 11:14am
tags:
Seattle Genetics, Adcetris, Hodgkin's lymphoma
Don't Get Too Worked Up Over Impax Laboratories' Earnings
Motley Fool
Thursday, June 14, 2012 - 11:09am
tags:
Impax Laboratories, earnings
Arena Pharmaceuticals: Rising Star Or Falling Knife?
Seeking Alpha
Thursday, June 14, 2012 - 8:42am
tags:
Arena Pharmaceuticals, obesity, lorcaserin, Contrave, Qnexa, Orexigen, Vivus
Teva announces results from GALA Phase III trial in MS
The Fly on the Wall
Thursday, June 14, 2012 - 8:19am
tags:
Teva Pharmaceuticals, MS, multiple sclerosis, glatiramer acetate

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.